Servicio de Anestesia, MD Anderson Cancer Center, Madrid, Spain.
Servicio de Urología, MD Anderson Cancer Center, Madrid, Spain.
Rev Esp Anestesiol Reanim (Engl Ed). 2022 Jan;69(1):25-33. doi: 10.1016/j.redare.2021.03.005. Epub 2022 Jan 13.
Surgical treatment during Covid-19 pandemic is controversial. Currently, most clinical guidelines advise to defer surgical patients during the Covid-19 pandemic, although the supporting data is sparse. We assumed that a Covid-19-free hospital, on the back of strong isolation measures and targeted screening, could reduce complications and enable us to continue treating high-risk patients.
Prospective study with retrospective analysis of 355 patients who had undergone nondeferrable oncological surgery between March 16th, 2020, and April 14th, 2020, at our institution. The aim of the study was to assess the hospital restructuring and surgical protocols to be able to safely handle non-deferrable surgeries during the first wave of the Covid-19 pandemic. We implemented structural changes and an updated surgical-anesthetic protocol in order to isolate Covid-19 patients from other surgical patients. Comprehensive targeted screening for Covid-19 patients was made. PCR tests were requested for suspected Covid-19 patients. We analyzed mortality and complications related to both surgery and Covid-19 during hospital admission and also 15 and 30 days after surgery. We compared it with a sample of similar patients in the pre-pandemic period.
Of the 355 patients enrolled in our study, 21 were removed due to Covid-19 infection, leaving a total of 334 patients in our final analysis. Post-operative complications were found in 37 patients (11.07%). Two patients died after surgery (0.6%). At the end of the study, Covid-19-related adverse outcomes were detected in six patients (1.79%). When comparing the complications of our original sample with the complications that occurred in the pre-covid era, we found no statistically significant differences.
Our results show that the surgical treatment of oncologic patients during the Covid-19 pandemic is safe, as long as the hospital performs surgeries under strict isolation measures and a robust screening method. It is necessary to select Covid-19 free hospitals for this matter in this and future pandemics.
在新冠疫情期间,外科手术治疗存在争议。目前,大多数临床指南建议在新冠疫情期间推迟手术患者,尽管支持数据很少。我们假设,在强大的隔离措施和有针对性的筛查的支持下,一家没有新冠病毒的医院可以减少并发症,并使我们能够继续治疗高危患者。
对 2020 年 3 月 16 日至 4 月 14 日期间在我院接受不可推迟的肿瘤手术的 355 例患者进行前瞻性研究和回顾性分析。本研究的目的是评估医院结构调整和外科手术方案,以便能够在新冠疫情第一波期间安全处理不可推迟的手术。我们实施了结构性变化和更新的手术-麻醉方案,以将新冠病毒患者与其他手术患者隔离开来。对新冠病毒患者进行了全面的有针对性的筛查。对疑似新冠病毒患者要求进行 PCR 检测。我们分析了住院期间以及手术后 15 天和 30 天与手术和新冠病毒相关的死亡率和并发症。并将其与大流行前同期的类似患者样本进行了比较。
在纳入本研究的 355 例患者中,有 21 例因新冠病毒感染被剔除,最终分析中共有 334 例患者。术后并发症发生在 37 例患者(11.07%)中。术后有 2 例患者死亡(0.6%)。在研究结束时,发现 6 例(1.79%)与新冠病毒相关的不良结果。当比较我们原始样本的并发症与大流行前时期发生的并发症时,我们没有发现统计学上的显著差异。
我们的结果表明,只要医院在严格的隔离措施和强大的筛查方法下进行手术,新冠疫情期间对肿瘤患者进行手术治疗是安全的。在这种情况下,以及在未来的大流行中,有必要选择没有新冠病毒的医院来进行手术。